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Purpose: Details on adequate care and prevalence of depression in long-term stroke after-
care are limited. We aimed to determine long-term depression rates after stroke and to test for
an association between depression and inadequate screening, socio-economic complications
and lack of sub-optimal care.
Patients and Methods: In this cross-sectional study, 57 patients were re-invited into the
clinic 2–3 years after stroke. Patients were interviewed about recalled screening concerning
depression and unmet needs. Depression, the patient’s social situation, and confounders were
assessed by standardized scores.
Results: In our study, 20% (n = 11) of patients were classified as depressed by the HDRS-17
score result. However, only 36% of all patients recalled to have been previously screened for
depression and only 43% of those patients also recalled out-patient screening. Patients
classified as depressed reported significantly lower recalled screening rates (9% vs 43%;
p = 0.036) and higher rates of self-reported unmet need with emotional problems (72% vs
18%; p < 0.001). Depression in our study was further associated with a worse socio-
economic situation, fewer social contacts, unmet needs with regard to emotional problems
and higher rates of recommendations to apply for additional social support.
Conclusion: Our data suggest that systematic out-patient screening for depression is lacking
in stroke aftercare. Furthermore, the high rate of unmet emotional needs, the poor socio-
economic situation and the higher rates of recommendations for social counselling and
application for benefits suggest an undersupply of care in the out-patient setting that is
more prominent in patients with depression and warrants further studies to investigate the
underlying causes.
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Plain Language Summary
The study was done to better understand how frequently depression occurs 2–3 years post-
stroke, whether it is continuously screened for and whether patients with post-stroke depres-
sion had more social problems than patients without depression.
We tested for depression by using a commonly used questionnaire asking for major
symptoms of the disease. We also assessed the socio-economic situation, the social contacts
and the housing situation of the patients and asked the patients whether a health-care
professional had previously asked them for symptoms of depression after stroke.
We found that very few patients were tested for symptoms of depression after stroke
during out-patient care. Compared to patients without depression, patients with a score result
indicating depression less frequently reported to have previously been asked for symptoms of
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depression after stroke. Furthermore, patients with depression
also had more social problems than patients without depression.
Finally, we found that all patients classified as depressed by
a questionnaire comprised of 17-items (HDRS-17) would also
have been detected by using a reduced version of the question-
naire consisting of only two questions.
Introduction
Depression after stroke remains a major clinical challenge
with a recent systematic review estimating a proportional
frequency for post-stroke depression of approximately
30%.1 It is associated with disability, poor quality of life,
increased mortality, social isolation and slow recovery2 as
well as with non-adherence to medication in different med-
ical conditions.3,4 Despite this, depression often remains
undertreated.5,6 Depressive symptoms after stroke can
occur directly after the event but also can arise in the course
of long-term disease development andmanagement.1 Similar
to other chronical diseases, the transfer from the hospital
setting (acute or rehabilitation) to out-patient aftercare pre-
sents a challenge for continuous care in stroke patients. Here,
deficits may limit the potential rehabilitation success as con-
tinuous care and training of function has been reported to
result in improvements up to several years after stroke-event
if provided with sufficient intensity.7 Hereby, general health,
opportunity and motivation for training are important factors
influencing success. A recent review focused on depression
as a general risk factor for organic disease and concluded,
that by inducing unfavorable pathophysiological and beha-
vioral processes, social and emotional loneliness contributes
to the link between depression and physical illness.8 Vice
versa it is well known that depression also is a common
complication caused by stroke.1 Underdiagnosed or inade-
quately treated depression therefore may represent a risk
factor for post-stroke complications. Current guidelines
state there is a need for more research to determine if screen-
ing for depression – in conjunction with collaborative care –
helps to reduce its prevalence.9 In particular, there is a lack of
evidence with regard to long-term care extending up to 2–3
years after stroke. Explicit recommendations on timing of
screening for depression and its relation to long-term preva-
lence, as well as the development of potential complications
do not exist. Current clinical guidelines highlight the need for
time-efficient screening tools suitable to identify patients
with post-stroke depression in the aftercare setting. Short
dichotomous screening tools, such as the PHQ-9 score have
been shown to be effective in the general population, how-
ever, have not yet been tested in stroke patients.9,10
Here, we aimed to investigate whether prevalent
depression was associated with a self-reported lack of
recalled screening for depression and care in the long-
term course after stroke. Further, we sought to test the
hypothesis that depression is associated with loss of social
support, a worse housing and financial situation, insuffi-
cient care and lower quality of life 2–3 years after stroke.
Moreover, we conducted exploratory tests of sensitivity
and specificity of a potential simple screening tool for
identifying patients with post-stroke depression.
Materials and Methods
Study-Design
The present analysis is part of the observational, cross-
sectional MAS-I study (clinical trial registration number
NCT02320994), which has been described previously.11
Briefly, MAS-I aimed to assess the needs and disease
burden of community-dwelling stroke patients and their
carers and to compare their treatment to evidence-based
guidelines by a stroke neurologist. We recruited partici-
pants employing purposive sampling of previous partici-
pants of two independent and completed hospital-based
acute stroke studies (a randomised-controlled trial
STRAWINSKI NCT0126454934 and an observational
study PREDICT NCT0107972835). Inclusion criteria
used in PREDICT were acute ischemic stroke of any
severity (NIHSS ≥ 1 at study inclusion, TIA excluded)
and any localization, symptom onset ≤36 h and age ≥18
years. Inclusion criteria used in STRAWINSKI were age
≥18 years and severe ischemic stroke in the middle cere-
bral artery (score of >9 on the National Institute of Health
Stroke Scale). In MAS-1, all previous participants of
STRAWINSKI and PREDICT living in the Berlin metro-
politan area 2–3 years after the event were invited to take
part and visit our out-patient clinic for a follow-up assess-
ment. No financial incentive was provided.11 The assess-
ment included a comprehensive interview and an
examination using the Post-Stroke-Checklist (PSC) as
well as validated standard measures of (among other
domains) depression, quality of life, secondary prevention
and social needs. Current use of medication was assessed
with a focus on secondary prevention. Recalled screening
for depression and history of intake of anti-depressant
medication was assessed based on self-reported informa-
tion and review of discharge letters.
To counter selection bias, we offered to pay travel costs
to and from our center.
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Scores and Outcome Measures
In our primary research question, we attempted to under-
stand which factors might contribute to the development of
prevalent depression in the long-term aftercare after
stroke. The main parameter of interest was self-reported
recalled screening and its association with depression
which was diagnosed using the HDRS-17 score. Further,
scores used included the Stroke Survivor Need Scale, the
Nikolaus Score and the EQ-5D-5L, the modified Rankin
Scale, the MoCA and the Post-Stroke Checklist (PSC).
Details on the above-described scores can be found in
the Supplementary methods section.
Statistical Analysis
Statistical analyses were performed using SPSS software
version 22.
Except for age where the assumption of normal distribu-
tion was not rejected by the Kolmogorov Smirnov test, all
other group comparisons were subjected to non-parametric
testing by Mann–Whitney-U, Fishers exact or chi-square
test. Differences between frequency outcomes were calcu-
lated by Fisher´s exact test where the expected frequency
count was <5 and by chi-square where this was not the case.
Correlations were calculated by Spearman´s Rho. Missing
data were subjected to listwise deletion. P-values related to
primary and secondary research questions were controlled
for multiple testing using the Benjamini-Hochberg proce-
dure. Due to the small number of participants for most part
of the analysis, we used simple parametric and non-
parametric statistical testing. However, to clarify whether
the association between recalled screening and depression
may have been confounded by age, cognition, years of
education, modified-Rankin scale and sex an explorative
logistic regression model correcting for the factors was
additionally carried out using Stata version 14.2.
Results
Prevalence, Recalled Screening and Care
and Consequences of Depression
Overall 516 subjects were invited out of which 57 patients
(11%) responded and were included in MAS-1.11 For 56 of
these patients depression was assessed using the HDRS-17
depression scale. Eleven (20%) of the assessed patients would
be diagnosed as depressed according to the score result.
Data about recalled screening for depression after stroke
were available from 55 of those 56 patients. According to the
patient's self-report only a minority (n=20; 36%) recalled to
have been screened for depression after stroke. To better under-
standwhether the prevalence of depressionmight be associated
with recalled screening we compared rates of self-reported
prior screening and prevalent depression according to HDRS-
17 score result. Recalled screening rates were 9% (n=1) in
patients who were diagnosed as depressed and 43% (n=19) in
non-depressed patients, resulting in a significant difference
(p=0.036) (Table 1). Furthermore, even in the group of patients
who indicated to have been previously screened for depression
less than 43% indicated screening had been done during the
out-patient phase of disease management. In order to exclude
potential modifiers or confounders causing the observed asso-
ciation between recalled screening and prevalent depression,
we additionally calculated a logistic regression model and
corrected for current age, sex, years of education, cognition
and modified Rankin scale (collected 3 months after stroke).
Also after correction, the association remained significant.
Also, in a direct comparison none of these factors differed
significantly between patients with and without prevalent
depression according to HDRS-17 score result (Table 2).
We furthermore found that eight of eleven (72%)
patients with and eight of 45 (18%) patients without
a score-based diagnosis of depression also expressed an
unmet need with regard to help with emotional problems
(defined as confusion/depression/crying) after the stroke
(p-value <0.001) (Table 1).
For 34 of our 56 patients, information on whether prior
anti-depressant medication had been prescribed was avail-
able. Altogether eleven of these 34 patients had a history
of prior treatment with anti-depressants mostly starting
during the stay in the acute or rehabilitation hospital due
to the acute presence of symptoms (such as crying/loss of
interest) for depression (Table 3).
Interestingly, five of eleven patients with anti-depressant
medication in our study still were classified as depressed
according to their current HDRS-17 result and four of these
five patients did not recall to have previously been screened
for depression (Table 3). Altogether the recalled screening
rate reported in patients with a history of prior anti-
depressant treatment did not differ from the overall recalled
screening rate for depression (36%) (Table 3).
Association Between Depression, Current
Social Situation, Medication Adherence and
Quality of Life
With regard to their current situation, patients with depres-
sion reported significantly lower social contacts and a worse
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socio-economic and housing situation than patients without
depression (Table 1). The socio-economic situation in our
study was evaluated by an experienced social worker who
recommended further mediation, counselling or application
for benefits if necessary. To better understand whether dif-
ferences in the socio-economic situation also reflected dif-
ferences in the need for further intervention, in a next step
we compared the rate of recommendations for counselling
and applications for benefits in depressed and non-
depressed patients. We found significantly higher recom-
mendation rates for further intervention in patients with
depression (Table 1).
These results remained significant even after correction
for multiple testing (Table 1). However, we observed no
association between depression and overall level of quality
of life in this group comparison. Despite of this post-hoc
analyses for correlation between HDRS-17 values with the
visual analogue scale of the EQ-5D-5L showed
a significant association (r2=−0.382, p =0.004).
Furthermore, also correlations between the assessments
used to determine the social situation and the HDRS-17
results were significant (Supplementary Table 1).
Performance of Single Items of the
HDRS-17 for Diagnosis of Depression
After Stroke
Lower rates of recalled out-patient screening in patients
with prevalent depression might be attributed to regular
screening using the standard tools is too time-consuming
Table 1 Overview of Recalled Screening, Quality of Life, Social Care and Unmet Emotional Long-Term Needs After Stroke are
Depicted in Patients with and Without Prevalent Depression
Hamilton Depression Scale Depression No
(n=45) (Cutoff
< 9)
Depression
Yes (n=11)
p-values Benjamini Hochberg Critical
Value (I/Number of Tests)
*Q(fdr)
Rank
(Order of
p-values)
Primary research question: association of recalled prior screening and unmet need for help with emotional problems with prevalent depression
Screening for depression yes (n) 19 (43% of all non-
depressed) (n=44)
1 (9% of all
depressed)
0.036 0.039 7
Unmet need with emotional
problems
8 (18% of all non-
depressed)
8 (72% of all
depressed)
<0.001 0.006 1
Secondary research questions: associations between depression and current complications/need for further care
Recommendation for mediation into
further socio-economic counselling
2 (5% of all non-
depressed)
4 (36% of all
depressed)
0.002 0.011 2
Nikolaus-score: socio-economic
situation (median (min-max/IQR))
2 (0–3/1) 1 (0–3/1) 0.010 0.017 3
Nikolaus-score: social-contact
(median (min-max/IQR))
5 (1–6/1) 4 (2–6/2) 0.014 0.022 4
Recommendation to apply for further
socio-economic care and benefits
2 (5% of all non-
depressed)
3 (27% of all
depressed)
0.017 0.028 5
Nikolaus-score: housing situation
(median (min-max/IQR))
9 (3–11/3) 8 (5–11/2) 0.029 0.033 6
EQ-5D-5L (visual analogue scale)
(median (min-max/IQR))
70 (30–100/28) 62
(40–85/26)
0.142 0.044 8
EQ-5D-5L–Index (median (min-max
/IQR))
0.81 (0.06–1/0.3) 0.84 (0.23–1/
0.53 (n=10))
0.276 0.05 9
Notes: Depicted are associations between recalled prior screening and prevalent depression measured by the HDRS-17 and between depression and its potential
complications. P-values are corresponding to Mann–Whitney-U or chi-square test where appropriate. P-values were controlled for multiple testing using the
Benjamini-Hochberg procedure. The false discovery rate (FDR) was set to 0.05. With regard to the socio-economic situation as well as with regard to unmet
need with emotional problems and recommendations to apply for further social-economic counselling and benefits p-values were smaller than the critical value
calculated by Benjamini-Hochberg.
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for general practitioners. Therefore, we aspired to explora-
tively test how a reduced version of the Hamilton depres-
sion scale using only two items in a dichotomous manner
would perform compared to the full 17-item version of the
Hamilton scale. When comparing single items of the
HDRS-17 (dichotomized in healthy or pathological irre-
spective of the strength of the items) differences between
depressed and non-depressed stroke patients (Figure 1)
were highest for loss of interest in work and other activ-
ities (Item 7), feelings of guilt (Item 2) and depressive
mood (Item 1) (Figure 1).
Items 1 and 7 of the HDRS-17 also represent the two
criteria that are necessary for a diagnosis of depression
according to the DSM-5 (depressive mood/loss of interest
or pleasure in work and other activities), so in a next step,
we strove to see how these items would compare to the
overall score with regard to sensitivity and specificity of
detecting depression. For a combination of item 1 and item
7, the sensitivity for detecting depressed patients was at
100%. In other words, all patients who were diagnosed as
depressed according to the 17-item version of the HDRS-
17, could also be detected by a two-item screening. The
Table 2 Patient Characteristics That are Potentially Associated with Depression
Depression No (n=45)
(HDRS-17 Cutoff < 9)
Depression Yes (n=11) p-values
Sex (Male, n (%)) 29 (64% of all non-depressed) 4 (36% of all depressed) 0.09
Thrombocyte inhibition yes (n) 34 (75% of all non-depressed) 6 (54% of all depressed) 0.18
Years in education (median (min-max/IQR)/mean (SD/95% CI) 14 (8–23/5)/14 (3/13–15) 15 (10–23/5)/
16 (4/13–18)
0.34
Statins yes (n) 36 (80% of all non-depressed) 8 (73% of all depressed) 0.44
Modified Rankin (3 months after stroke median (min-max/IQR)) 2 (0–4/2) (n=43) 2 (1–5/3) 0.46
Anticoagulation yes (n) 14 (31% of all non-depressed) 4 (36% of all depressed) 0.74
Age (median(min-max/IQR)/mean (SD/95% CI)) 73 (42–86/15)/
70 (10/66–73)
66 (63–86/7)/
69 (8/64–75)
0.70
Cognition (MoCA Score) (median (min-max)/IQR) 24 (6–30/5) 27 (17–29/8) 0.23
Notes: Factors potentially influencing the associations of prior screening with depression and/or the association of depression with the development of complications.
Depicted are differences in potential confounders or mediators of the association between depression and prior screening for depression or depression and its
complications. P-values are corresponding to Mann–Whitney U, t-test or chi-square test where appropriate. For score data, median as well as minimum and maximum
values and the interquartile range are indicated. For continuous variables (age and years in education) additionally the means, standard deviations and 95% confidence
intervals are reported.
Table 3 Overview of Intake of Antidepressant Medication After Stroke
No Evidence for Prior Post-Stroke
Antidepressant Medication
Evidence for Prior Post-Stroke
Antidepressant Medication
Sum
No prior
screening
reported
Depression according to
HDRS-17
4 4 8
No Depression according to
HDRS-17
13 3 16
Prior screening
reported
Depression according to
HDRS-17
0 1 1
No Depression according to
HDRS-17
6 3 9
Sum 23 11 34
Notes: Reported are the numbers for patients with and without prior anti-depressant medication and their distribution across the groups with and without prevalent
depression and prior screening for depression.
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specificity for using only two questions was 0.91 when
compared with the overall HDRS-17 (Table 4).
For item 8 (asking about “feelings of anxiety and
depression”) of the PSC, the sensitivity and specificity
for detecting depression in comparison to the HDRS-17
was lower than for the two-item screenings (0.91 and 0.71,
respectively). However, when comparing the single items,
the sensitivity for detecting depression was highest for
item 8 of the PSC (91%), compared to 82% and 64% of
the single items 1 and 7 of the HDRS-17.
Among the single items of the HDRS-17 for which the
strength of the rating also was highly correlated (Table 5)
with overall score results, again were “interest in work and
other activities” (Item 7 of the HDRS-17), depressive
mood (Item 1) and their combination.
Discussion
With low-recalled screening rates we observed a high rate
of manifest depression 2 to 3 years after stroke onset.
Patients with depression further reported experiencing
a poor social situation and less emotional support, which
might increase the risk for developing additional medical
complications such as cardiovascular disease, metabolic
syndrome or chronic pain.8 Furthermore, social counsel-
ling and application for benefits were recommended more
frequently in patients with depression. The lower rate of
0
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Percentage of patients positive for single HRDS-17 items
non-depressed
depressed
Figure 1 HDRS 17-items.
Notes: Impairments in patients with and without post-stroke depression. Shown are the percentages of depressed vs non-depressed patients who are positive for the single
items.
Table 4 Negative and Positive Predictive Value, Sensitivity and Specificity for a Combination of Two and Single Items in Detecting
Depression
Negative
Predictive Value
Positive
Predictive Value
Sensitivity Specificity p-value
Depressed mood (item 1) and interest in work (item 7) (if
one pos., whole item pos.)
1 0.73 1 91 <0.001
Item 7 work 0.92 0.88 64 97 <0.001
Item 1 depressed mood 0.95 0.69 82 91 <0.001
PSC item 8 (feelings of anxiety or depression) 0.97 0.43 91 71 <0.001
Notes: Positive and negative predictive values, of HDRS-17 items work, feelings of guilt, depressed mood and combined items. P-values indicate results of the Fisher´s exact
test confirming the dependence of the results of the 2 vs 17 item screening.
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recalled screening, the higher rates of expressed unmet
need with regard to emotional problems and the under-
supply of social care may indicate that in patients with
depression social problems and emotional needs currently
were not adequately addressed during aftercare for stroke.
Since some of the patients who did not recall screening
already had received prior anti-depressant medication
mostly initiated during the hospital stay, a lack of adequate
care in the out-patient setting could indicate that further
treatment recommendations for patients with depression
were not adequately followed up after the transfer to the
out-patient setting. However, this remains speculative,
since we had only limited information on the anti-
depressant medication used and no information on the
circumstances of prescription or whether and which
recommendations for out-patient treatment were given
specifically. Future studies should investigate this issue in
more detail considering that anti-depressant drugs might
also be prescribed prophylactically or for the treatment of
post–stroke pain.12 Furthermore, response rates to anti-
depressant treatment can change over time. Therefore,
continuous screening for disease symptoms may be essen-
tial to improve out-patient treatment and adequately
address emotional needs. Simplified screening methods
for out-patient depression after stroke might support gen-
eral practitioners to monitor the disease in a time-effective
fashion. Our data suggest that loss of interest in work and
other activities (Item 7 of the HDRS-17) in combination
with depressed mood (Item 1) in our study displayed the
same sensitivity as the 17-item HDRS-17 for detecting
depression in our sample.
Previous work found two-question-screenings for depres-
sion to be similarly accurate as more extensive instruments13
and mail-delivered short versions to be similar to long
versions of self-assessment tools (Beck depression inven-
tory) after stroke.14 The Beck depression inventory (self-
assessment) and the HDRS-17 (interviewer-based face to
face assessment) moreover have been evaluated to be simi-
larly useful in the detection of depression.15 Interviewer-
based ratings and diagnoses, however, compares favorably
to real-life situations when patients visit their general practi-
tioner in out-patient aftercare. For this type of interview,
studies confirming the efficiency of using reduced score
versions of face-to-face assessments such as the HDRS-17
during the post-stroke aftercare have been lacking so far.
Previous studies using a 9 item version of the Hamilton
depression inventory indicate that these versions also dis-
played high internal consistency and test –retest reliability.16
However, they were never established in clinical routine.
Other two-item versions of screening tools for depression
such as the PHQ-2 have been tested successfully for depres-
sion but were not validated in stroke patients.9 Our small
study was not powered for a detailed analysis of the precision
of a two-item score. However, an exploratory comparison of
the full versus the two-item version, data collected in our
study indicated that using verbal screening including two
items in a dichotomous manner in our study would have
left no patient with depression undetected.
Limitations of our study include first of all the small
size of our exploratory study. Due to this, we can only
draw limited conclusions. Larger long-term studies follow-
ing the intake and effects of antidepressant medication are
needed to confirm our findings. However, the patients
were well characterized with the exception that informa-
tion on prior anti-depressant medication intake was only
available for 34 of 57 and for nine of eleven patients
that were classified as depressed according to the HDRS-
17. Data collected in smaller studies can be prone to
different forms of bias and data on screening in our
study were self-reported and collected retrospectively.
Therefore, we cannot exclude a recall bias with regard to
the screening for depression. Such a bias may distort our
results as patients with depression tend to have cognitive
impairments as well.17 However, in our study, we did not
see differences in people with and without depression with
regard to cognitive impairment and results remained sig-
nificant also after adjusting for confounding factors includ-
ing cognition. Furthermore, although we offered
transportation we cannot exclude a selection bias concern-
ing patients unable to attend our study center.
Even though we controlled for a wide panel of poten-
tial confounders we did not control for stroke lesion.
Table 5 Correlations Between Overall HDRS-17 Value and
Ratings for Single Items of the Score
Correlation with HDRS-
17 (Spearman's Rho)
Item 1: depressed mood 0.567 (p-value<0.001)
Item 7: interest in work/activities 0.566 (p-value <0.001)
Item 10: anxiety psychological 0.634 (p-value<0.001)
Item 11: anxiety somatic including
symptoms such as increased heart
rate and breathing, diarrhea, headache
0.537 (p-value <0.001)
Items 1+7 0.669 (p-value <0.001)
Notes: Correlations between overall HDRS-17 value and single items of the score.
Shown are items that were most highly correlated with the overall score-result.
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However, the type of lesion induced by the stroke may
explain some of the variability associated with depression,
but – especially since differences with regard to cognition
did not seem to be an issue – is unlikely to affect recalled
screening or the quality of medical support with regard to
emotional problems. Therefore, the type of lesion should
not confound our results with regard to the association
between recalled screening and depression.
Due to the cross-sectional design of our study, we have
only limited information on the status of depression and
unmet need at stroke onset. Therefore, we cannot be cer-
tain whether the outcomes such as unmet need for support
with emotional problems or lower social-support represent
consequences of the depression or should be considered
risk factors in the development of the disease. In any case,
social loneliness has previously been reported to provide
a link between depression and organic disease.8 Also, the
fact that further socio-economic counselling and care in
our study was recommended at significantly higher rates in
patients with depression underlines the need for detection
of depression in long-term stroke aftercare to identify
vulnerable patients that may not be able to organize opti-
mal care for themselves.
Finally, the results from the two-item screening are not
independent from the overall results of the HDRS-17.
Consequently, the high sensitivity rate for detecting
depression using the two-item version of the HDRS-17
needs to be interpreted with great care.
In conclusion, we found that a minority of patients
recalled to have been screened for post-stroke depres-
sion. In patients with depression a lower rate of recalled
screening, a worse social situation and more unmet need
with emotional problems were observed. Patients with
post-stroke depression further were more often recom-
mended to apply for social support and benefits, indicat-
ing that available resources were not being used to the
extend they were needed to ensure optimal stroke after-
care. Undersupply of care in patients with post-stroke
depression might induce a vicious circle increasing the
risk for additional medical complications leading to
increased mortality and disability.2,5 Results of our
exploratory analysis further question whether using
only two items of the HDRS-17 scale may be sufficient
for detecting patients at risk for post-stroke depression
when time does not allow for more detailed assessment
of all patients. This finding could be important, since
previous studies have demonstrated that unassisted judg-
ments of general practitioners for depression in their
patients lack sensitivity.18 Our findings warrant larger,
prospective, multicenter studies exploring in more detail
the effect of a better treatment and a more efficient
screening for post-stroke depression in improving medi-
cal and social outcomes in the long-term course of
stroke.
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